NAFDAC Boss Praised for Health Sector Transformation
NAFDAC's Director-General Prof. Moji Adeyeye earns commendation for transformational leadership that's reshaping Nigeria's healthcare landscape and regulatory standards.
NAFDAC's Director-General Prof. Moji Adeyeye earns commendation for transformational leadership that's reshaping Nigeria's healthcare landscape and regulatory standards.
Edo State announces groundbreaking pharmaceutical manufacturing initiative to produce essential medicines locally by 2026, reducing import dependency and creating thousands of jobs.
Global pharmaceutical giant Pfizer experiences significant profit decline amid falling COVID-19 product sales. Analysis of impact on Nigerian healthcare market and future outlook.
NUPRC CEO Gbenga Komolafe set to share Nigeria's oil and gas regulatory expertise with African lawmakers, focusing on sustainable energy development and economic growth across the continent.
Massive €10.2 million investment aims to boost local drug manufacturing, reduce import dependency, and create thousands of jobs in Nigeria's healthcare sector.
Breaking: European Union and France launch massive €10.2 million investment to transform Nigeria's local drug manufacturing capacity and healthcare security.
France's anti-fraud agency uncovers shocking discovery of childlike sex dolls on Shein's platform, sparking global outrage and regulatory concerns.
ACPN demands immediate government action against unlicensed drug distribution in healthcare facilities, warning of dire consequences for patient safety and public health.
President Tinubu's administration takes decisive action to revolutionize Nigeria's pharmaceutical sector with new policies aimed at boosting local medicine manufacturing and reducing import dependency.
The Corporate Affairs Commission takes a firm stand against coercion tactics, affirming commitment to lawful operations and regulatory integrity in Nigeria's business landscape.
Major pharmaceutical battle intensifies as Novo Nordisk challenges Pfizer in high-stakes acquisition race for obesity treatment specialist Metsera, reshaping the weight-loss drug market.
British drugmaker GSK raises 2025 profit guidance as Nigeria's tariff reforms create favorable market conditions. Discover how this impacts healthcare costs and medicine availability.
Financial experts reveal how supportive regulators could transform Nigeria's treasury management landscape, driving economic growth and attracting crucial investments.